Kairos Ventures has raised $74.7 million to date for its Kairos Venture Partners II, per a SEC filing. The Beverly Hills-headquartered firm has set a $150 million target and began fundraising in 2017. The SEC filing did not disclose whether the capital raise constituted a final or interim close.
The fund will target venture capital opportunities in biotechnology and healthcare sectors in the United States.Â
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: